© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 14, 2018
Investigators also found that opiate agonist therapy could have a positive effect in limiting reinfection rates after patients achieve SVR.
December 13, 2018
For patients with chronic liver disease, opioid prescriptions are common, and high-risk prescriptions are associated with hepatic decompensation, especially ascites.
December 11, 2018
ALD-related hospitalizations grew from 2008 to 2014, especially among women, Asians, Hispanics, and people 50 to 69 years of age.
December 10, 2018
No studies to-date have looked at the combined risk of mortality for patients with thrombocytopenia and severe hepatic steatosis.
December 07, 2018
The leading etiologies for chronic-liver-disease-related-deaths over the last decade can be explained by NAFLD and alcoholic liver disease.
A new study confirms that HCV-RNA can be found in the nasal and rectal fluids of patients with high viral loads of HCV, raising the possibility of HCV transmission via these fluids.
A low dose of TDF may help to preserve renal function and maintain viral suppression in patients with chronic hepatitis B virus infection, even those with advanced liver disease.
December 06, 2018
After the therapy was approved by the FDA in May, investigators are anticipating its first real-world data will paint a clearer picture of its potential.
November 28, 2018
Cirrhotic patients with variceal bleeding were found to have greater morbidity in association with obesity.
November 23, 2018
How fatty liver disease and NASH—as well as the comorbidities associated with them—highlighted this year's discussions.